Pine Valley Investments’s AbbVie ABBV Stock Holding History

Pine Valley Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.1M	Sell	72,077 -3,483	-5%	-$749K	0.72%	31
2026 Q1	$16.4M	Buy	75,560 +1,727	+2%	+$383K	0.75%	29
2025 Q4	$16.9M	Buy	73,833 +626	+0.9%	+$143K	0.78%	31
2025 Q3	$17M	Sell	73,207 -7,052	-9%	-$1.44M	0.83%	24
2025 Q2	$14.9M	Buy	80,259 +948	+1%	+$176K	0.83%	29
2025 Q1	$16.6M	Sell	79,311 -3,528	-4%	-$686K	1.01%	21
2024 Q4	$14.7M	Buy	82,839 +22,052	+36%	+$4.05M	0.88%	22
2024 Q3	$12M	Buy	60,787 +6,814	+13%	+$1.27M	0.73%	28
2024 Q2	$9.26M	Buy	53,973 +2,075	+4%	+$344K	0.61%	36
2024 Q1	$9.45M	Buy	51,898 +2,568	+5%	+$443K	0.64%	33
2023 Q4	$7.64M	Buy	49,330 +4,850	+11%	+$707K	0.55%	37
2023 Q3	$6.63M	Buy	44,480 +7,400	+20%	+$1.09M	0.6%	36
2023 Q2	$5M	Buy	37,080 +19,352	+109%	+$2.84M	0.49%	54
2023 Q1	$2.4M	Buy	+17,728	New	+$2.71M	0.36%	64

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Pine Valley Investments's ABBV Position: Q2 2026 in Review

Pine Valley Investments reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $749K and leaving 72,077 shares worth $18.1M. The position accounts for 0.72% of the portfolio, ranked #31.

Pine Valley Investments first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pine Valley Investments held 72,077 shares of AbbVie worth $18.1M as of Q2 2026.
Pine Valley Investments sold 3,483 AbbVie shares in Q2 2026, an estimated $749K.
AbbVie made up 0.72% of Pine Valley Investments's portfolio in Q2 2026, its #31 holding.
Pine Valley Investments first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.